Physician

Enrique Peralta

According to 2025 Medicare claims, Enrique Peralta (NPI: 1346237534) practices ophthalmology in the St. Louis, MO-IL market, with the plurality of this provider's patient population coming from Madison, IL. This provider's primary affiliated billing organization is JFJ EYECARE, LTD (NPI: 1376586685; TIN: 371099270) and primary practice location at 62040-4148.

Peralta's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 456 traditional Medicare patients, billed 16,626 HCPCS/CPT codes, and received $932,289 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 768 prescription claims across 274 beneficiaries totaling $39,251 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 26 records totaling $968. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $597,148 to $932,289. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $43,196 and ending at $39,251. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$477K$955K2015 Medicare payment: $597,148 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $651,004 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $608,257 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $714,826 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $707,088 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $747,889 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $954,662 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $798,378 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $743,504 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $932,289 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201557513,010$597,148
201660511,004$651,004
20175989,913$608,257
20186249,092$714,826
20195597,874$707,088
20204825,088$747,889
20215146,443$954,662
20224877,151$798,378
202349010,797$743,504
202445616,626$932,289

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$28K$56K2015 Drug cost: $43,196 (USD; Tot_Drug_Cst)2016 Drug cost: $40,502 (USD; Tot_Drug_Cst)2017 Drug cost: $36,940 (USD; Tot_Drug_Cst)2018 Drug cost: $33,653 (USD; Tot_Drug_Cst)2019 Drug cost: $23,410 (USD; Tot_Drug_Cst)2020 Drug cost: $28,000 (USD; Tot_Drug_Cst)2021 Drug cost: $52,108 (USD; Tot_Drug_Cst)2022 Drug cost: $53,744 (USD; Tot_Drug_Cst)2023 Drug cost: $56,380 (USD; Tot_Drug_Cst)2024 Drug cost: $39,251 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015255677$43,196
2016232558$40,502
2017217519$36,940
2018256592$33,653
2019163411$23,410
2020163415$28,000
2021243784$52,108
2022244744$53,744
2023249662$56,380
2024274768$39,251

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system258361$85
67028Injection of drug into eye202791$83
J9035Injection, bevacizumab, 10 mg130439$55
99212Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more186265$35
92134Imaging of retina3851,156$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1494,534$5,681
LumiganBimatoprost11491$4,599
Ketorolac TromethamineKetorolac Tromethamine1495,008$3,266
Tobramycin-DexamethasoneTobramycin/Dexamethasone541,237$2,257
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol12380$1,089

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.26$968Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Enrique Peralta?

Tedicare shows public-source Medicare data for Enrique Peralta (NPI 1346237534), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Enrique Peralta have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Enrique Peralta?

Enrique Peralta is linked to JFJ EYECARE, LTD (billing NPI 1376586685) in the available physician profile data.

Does Enrique Peralta have Open Payments data?

Enrique Peralta has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.